These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10787075)

  • 1. Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma.
    Huang YH; Wu JC; Lui WY; Chau GY; Tsay SH; Chiang JH; King KL; Huo TI; Chang FY; Lee SD
    World J Surg; 2000 May; 24(5):551-5. PubMed ID: 10787075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study.
    Ono T; Nagasue N; Kohno H; Hayashi T; Uchida M; Yukaya H; Yamanoi A
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-18-S6-25. PubMed ID: 9151912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
    Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K
    Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial.
    Lai EC; Lo CM; Fan ST; Liu CL; Wong J
    Arch Surg; 1998 Feb; 133(2):183-8. PubMed ID: 9484732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma.
    Kwok PC; Lam TW; Lam PW; Tang KW; Chan SC; Hwang JS; Cheung MT; Tang DL; Chung TK; Chia NH; Wong WK; Chan MK; Lo HY; Lam WM
    J Gastroenterol Hepatol; 2003 Apr; 18(4):450-5. PubMed ID: 12653895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma.
    Kim DY; Ahn SH; Kim SU; Choi SB; Lee KH; Park MS; Park JY; Lee DY; Han KH; Kim KS
    Oncology; 2011; 81(3-4):184-91. PubMed ID: 22067673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
    Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
    Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
    Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
    Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemolipiodolization reduces early recurrence derived from intrahepatic metastasis of hepatocellular carcinoma after hepatectomy.
    Ueno M; Uchiyama K; Ozawa S; Hayami S; Shigekawa Y; Tani M; Yamaue H
    Ann Surg Oncol; 2011 Dec; 18(13):3624-31. PubMed ID: 21614626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
    Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
    Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection.
    Chen LT; Chen MF; Li LA; Lee PH; Jeng LB; Lin DY; Wu CC; Mok KT; Chen CL; Lee WC; Chau GY; Chen YS; Lui WY; Hsiao CF; Whang-Peng J; Chen PJ;
    Ann Surg; 2012 Jan; 255(1):8-17. PubMed ID: 22104564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postoperative adjuvant arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma].
    Nakashima K; Aramaki M; Kawano K; Yoshida T; Kim YI; Kitano S; Kobayashi M
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1483-5. PubMed ID: 7574738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.
    Olthoff KM; Rosove MH; Shackleton CR; Imagawa DK; Farmer DG; Northcross P; Pakrasi AL; Martin P; Goldstein LI; Shaked A
    Ann Surg; 1995 Jun; 221(6):734-41; discussion 731-43. PubMed ID: 7794077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.
    Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW
    Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials.
    Ono T; Yamanoi A; Nazmy El Assal O; Kohno H; Nagasue N
    Cancer; 2001 Jun; 91(12):2378-85. PubMed ID: 11413528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
    Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
    Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma.
    Takenaka K; Yoshida K; Nishizaki T; Korenaga D; Hiroshige K; Ikeda T; Sugimachi K
    Am J Surg; 1995 Apr; 169(4):400-4; discussion 405. PubMed ID: 7694977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.